Berger, Jeffrey S.
Funding for this research was provided by:
AstraZeneca
Article History
First Online: 10 July 2018
Compliance with Ethical Standards
:
: Medical writing support provided by Prime Global was funded by AstraZeneca. Open access fees were funded by AstraZeneca.
: Dr. Berger has conducted research and sat on advisory boards for AstraZeneca and Janssen. He has also sat on an advisory board for Merck. Dr. Berger did not receive any financial incentive for preparing this manuscript and declares no other potential conflicts of interest that might be relevant to the contents of this manuscript.